Arcutis Biotherapeutics (ARQT) Shares Outstanding (2020 - 2025)
Historic Shares Outstanding for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $120.3 million.
- Arcutis Biotherapeutics' Shares Outstanding rose 281.2% to $120.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.3 million, marking a year-over-year increase of 281.2%. This contributed to the annual value of $117.8 million for FY2024, which is 2176.02% up from last year.
- Arcutis Biotherapeutics' Shares Outstanding amounted to $120.3 million in Q3 2025, which was up 281.2% from $119.8 million recorded in Q2 2025.
- Arcutis Biotherapeutics' Shares Outstanding's 5-year high stood at $120.3 million during Q3 2025, with a 5-year trough of $49.9 million in Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $61.6 million (2023), whereas its average is $80.7 million.
- As far as peak fluctuations go, Arcutis Biotherapeutics' Shares Outstanding skyrocketed by 155.87% in 2023, and later skyrocketed by 8913.95% in 2024.
- Arcutis Biotherapeutics' Shares Outstanding (Quarter) stood at $50.3 million in 2021, then rose by 21.45% to $61.0 million in 2022, then surged by 58.57% to $96.8 million in 2023, then rose by 21.76% to $117.8 million in 2024, then grew by 2.07% to $120.3 million in 2025.
- Its last three reported values are $120.3 million in Q3 2025, $119.8 million for Q2 2025, and $119.1 million during Q1 2025.